Crossmark

Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: a systematic review & meta-analysis

Published Online: 2022-06-17

Published Print: 2022-08

Authors

Arastu, Naazneen

Cummins, Olivia

Uribe, Wanda

Nemec, Eric C. https://orcid.org/0000-0001-7794-6732
License Information

Text and Data Mining valid from 2022-06-17

Version of Record valid from 2022-06-17
More Information

Article History

Received: 11 November 2021

Revised: 6 May 2022

Accepted: 8 May 2022

First Online: 17 June 2022

Conflicts of interest

: The authors declare no conflicts of interest.

Document is current